(Q43708764)

26 November 2017

title

Novel approaches to augment adeno-associated virus type-2 endocytosis and transduction (English)

1 reference

26 November 2017

Ahter D Sanlioglu

1

1 reference

26 November 2017

Bahri Karacay

2

1 reference

26 November 2017

Peter K Benson

3

1 reference

26 November 2017

John F Engelhardt

4

1 reference

26 November 2017

Salih Sanlioglu

5

1 reference

26 November 2017

publication date

1 August 2004

1 reference

26 November 2017

1 reference

26 November 2017

volume

104

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

51-59

1 reference

Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Selective gene expression in brain microglia mediated via adeno-associated virus type 2 and type 5 vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Structural and functional heterogeneity of integrated recombinant AAV genomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Recombinant adeno-associated virus for muscle directed gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Characterization of tissue tropism determinants of adeno-associated virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Selective extraction of polyoma DNA from infected mouse cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

A Rac1 effector site controlling mitogenesis through superoxide production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Protection from reoxygenation injury by inhibition of rac1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Adenovirus and adeno-associated virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Selective inhibition of l kappaB alpha phosphorylation and HIV-1 LTR-directed gene expression by novel antioxidant compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Quercetin inhibits hydrogen peroxide (H2O2)-induced NF-kappaB DNA binding activity and DNA damage in HepG2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

A requirement for the rac1 GTPase in the signal transduction pathway leading to cardiac myocyte hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Two independent molecular pathways for recombinant adeno-associated virus genome conversion occur after UV-C and E4orf6 augmentation of transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Cellular redox state alters recombinant adeno-associated virus transduction through tyrosine phosphatase pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Rate limiting steps of AAV transduction and implications for human gene therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Enhancement of Recombinant Adeno-Associated Virus Type 2-Mediated Transgene Expression in a Lung Epithelial Cell Line by Inhibition of the Epidermal Growth Factor Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Mutational analysis of novel effector domains in Rac1 involved in the activation of nicotinamide adenine dinucleotide phosphate (reduced) oxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Identification of possible reactive oxygen species involved in ultraviolet radiation-induced oxidative DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

7 January 2021

Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

7 January 2021

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

7 January 2021

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.03.002

7 January 2021

10.1016/J.VIRUSRES.2004.03.002

Identifiers

DOI

1 reference

26 November 2017

1 reference